文献速递传染病防控与疫情报告免疫规划慢病防控与筛查

基于医院行政数据的COVID-19与心肌炎关联分析(美国,2020年3月-2021年1月)

Association Between COVID-19 and Myocarditis Using Hospital-Based Administrative Data - United States, March 2020-January 2021.
PubMed 文献 · MMWR Morb Mortal Wkly Rep · 2021-09-03

CDC利用覆盖900余家医院的大型行政数据库评估COVID-19与心肌炎的关联。2020年心肌炎住院人次较2019年升高42.3%;2020年3月至2021年1月,COVID-19患者心肌炎风险为0.146%,非COVID-19患者为0.009%,调整后风险比为15.7(95%CI 14.1-17.2),且风险随年龄组变化。

要点

  • 2020年心肌炎住院人次较2019年升高42.3%。
  • COVID-19患者心肌炎风险0.146%,非COVID-19患者0.009%。
  • 调整后COVID-19患者心肌炎风险为非COVID-19者的15.7倍(95%CI 14.1-17.2)。

核心结论

  • COVID-19与心肌炎风险显著升高相关,且风险随年龄组不同而变化。

研究设计与样本

  • 利用美国900余家医院医疗就诊行政数据库的回顾性分析,评估2020年3月至2021年1月COVID-19与心肌炎的关联。

主要发现

  • 2020年心肌炎住院人次较2019年升高42.3%。
  • 2020年3月至2021年1月,COVID-19患者心肌炎风险为0.146%,非COVID-19患者为0.009%。
  • 调整患者和医院特征后,COVID-19患者心肌炎风险平均为非COVID-19者的15.7倍(95%CI 14.1-17.2)。
  • 按年龄组,风险比从16-39岁约7.0到<16岁或≥75岁>30.0。
  • 总体而言,无论有无COVID-19,心肌炎均不常见。

关键数值与推荐

  • 心肌炎住院人次2020年较2019年升高42.3%。
  • COVID-19患者心肌炎风险0.146%,非COVID-19患者0.009%。
  • 调整后风险比15.7(95%CI 14.1-17.2)。
  • 年龄组风险比:16-39岁约7.0,<16岁或≥75岁>30.0。

临床怎么用

  • 应实施包括疫苗接种在内的循证COVID-19预防策略,以降低COVID-19及其相关并发症的公共卫生影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Viral infections are a common cause of myocarditis, an inflammation of the heart muscle (myocardium) that can result in hospitalization, heart failure, and sudden death (1). Emerging data suggest an association between COVID-19 and myocarditis (2-5). CDC assessed this association using a large, U.S. hospital-based administrative database of health care encounters from >900 hospitals. Myocarditis inpatient encounters were 42.3% higher in 2020 than in 2019. During March 2020-January 2021, the period that coincided with the COVID-19 pandemic, the risk for myocarditis was 0.146% among patients diagnosed with COVID-19 during an inpatient or hospital-based outpatient encounter and 0.009% among patients who were not diagnosed with COVID-19. After adjusting for patient and hospital characteristics, patients with COVID-19 during March 2020-January 2021 had, on average, 15.7 times the risk for myocarditis compared with those without COVID-19 (95% confidence interval [CI] = 14.1-17.2); by age, risk ratios ranged from approximately 7.0 for patients aged 16-39 years to >30.0 for patients aged <16 years or ≥75 years. Overall, myocarditis was uncommon among persons with and without COVID-19; however, COVID-19 was significantly associated with an increased risk for myocarditis, with risk varying by age group. These findings underscore the importance of implementing evidence-based COVID-19 prevention strategies, including vaccination, to reduce the public health impact of COVID-19 and its associated complications.

来源:MMWR Morb Mortal Wkly Rep,查看原文。版权归原作者所有。

引用

  1. Boehmer TK, Kompaniyets L, Lavery AM, et al. Association Between COVID-19 and Myocarditis Using Hospital-Based Administrative Data - United States, March 2020-January 2021. MMWR Morb Mortal Wkly Rep. 2021. PMID: 34473684. doi:10.15585/mmwr.mm7035e5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。